Harnish Mukesh Naik , Xiangchen Cai , Pranay Ladiwala , Jayanth Venkatarama Reddy , Michael J. Betenbaugh , Maciek R. Antoniewicz
{"title":"Elucidating uptake and metabolic fate of dipeptides in CHO cell cultures using 13C labeling experiments and kinetic modeling","authors":"Harnish Mukesh Naik , Xiangchen Cai , Pranay Ladiwala , Jayanth Venkatarama Reddy , Michael J. Betenbaugh , Maciek R. Antoniewicz","doi":"10.1016/j.ymben.2024.03.002","DOIUrl":null,"url":null,"abstract":"<div><p>The rapidly growing market of biologics including monoclonal antibodies has stimulated the need to improve biomanufacturing processes including mammalian host systems such as Chinese Hamster Ovary (CHO) cells. Cell culture media formulations continue to be enhanced to enable intensified cell culture processes and optimize cell culture performance. Amino acids, major components of cell culture media, are consumed in large amounts by CHO cells. Due to their low solubility and poor stability, certain amino acids including tyrosine, leucine, and phenylalanine can pose major challenges leading to suboptimal bioprocess performance. Dipeptides have the potential to replace amino acids in culture media. However, very little is known about the cleavage, uptake, and utilization kinetics of dipeptides in CHO cell cultures. In this study, replacing amino acids, including leucine and tyrosine by their respective dipeptides including but not limited to Ala-Leu and Gly-Tyr, supported similar cell growth, antibody production, and lactate profiles. Using <sup>13</sup>C labeling techniques and spent media studies, dipeptides were shown to undergo both intracellular and extracellular cleavage in cultures. Extracellular cleavage increased with the culture duration, indicating cleavage by host cell proteins that are likely secreted and accumulate in cell culture over time. A kinetic model was built and for the first time, integrated with <sup>13</sup>C labeling experiments to estimate dipeptide utilization rates, in CHO cell cultures. Dipeptides with alanine at the N-terminus had a higher utilization rate than dipeptides with alanine at the C-terminus and dipeptides with glycine instead of alanine at N-terminus. Simultaneous supplementation of more than one dipeptide in culture led to reduction in individual dipeptide utilization rates indicating that dipeptides compete for the same cleavage enzymes, transporters, or both. Dipeptide utilization rates in culture and cleavage rates in cell-free experiments appeared to follow Michaelis-Menten kinetics, reaching a maximum at higher dipeptide concentrations. Dipeptide utilization behavior was found to be similar in cell-free and cell culture environments, paving the way for future testing approaches for dipeptides in cell-free environments prior to use in large-scale bioreactors. Thus, this study provides a deeper understanding of the fate of dipeptides in CHO cell cultures through an integration of cell culture, <sup>13</sup>C labeling, and kinetic modeling approaches providing insights in how to best use dipeptides in media formulations for robust and optimal mammalian cell culture performance.</p></div>","PeriodicalId":18483,"journal":{"name":"Metabolic engineering","volume":null,"pages":null},"PeriodicalIF":6.8000,"publicationDate":"2024-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Metabolic engineering","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1096717624000375","RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The rapidly growing market of biologics including monoclonal antibodies has stimulated the need to improve biomanufacturing processes including mammalian host systems such as Chinese Hamster Ovary (CHO) cells. Cell culture media formulations continue to be enhanced to enable intensified cell culture processes and optimize cell culture performance. Amino acids, major components of cell culture media, are consumed in large amounts by CHO cells. Due to their low solubility and poor stability, certain amino acids including tyrosine, leucine, and phenylalanine can pose major challenges leading to suboptimal bioprocess performance. Dipeptides have the potential to replace amino acids in culture media. However, very little is known about the cleavage, uptake, and utilization kinetics of dipeptides in CHO cell cultures. In this study, replacing amino acids, including leucine and tyrosine by their respective dipeptides including but not limited to Ala-Leu and Gly-Tyr, supported similar cell growth, antibody production, and lactate profiles. Using 13C labeling techniques and spent media studies, dipeptides were shown to undergo both intracellular and extracellular cleavage in cultures. Extracellular cleavage increased with the culture duration, indicating cleavage by host cell proteins that are likely secreted and accumulate in cell culture over time. A kinetic model was built and for the first time, integrated with 13C labeling experiments to estimate dipeptide utilization rates, in CHO cell cultures. Dipeptides with alanine at the N-terminus had a higher utilization rate than dipeptides with alanine at the C-terminus and dipeptides with glycine instead of alanine at N-terminus. Simultaneous supplementation of more than one dipeptide in culture led to reduction in individual dipeptide utilization rates indicating that dipeptides compete for the same cleavage enzymes, transporters, or both. Dipeptide utilization rates in culture and cleavage rates in cell-free experiments appeared to follow Michaelis-Menten kinetics, reaching a maximum at higher dipeptide concentrations. Dipeptide utilization behavior was found to be similar in cell-free and cell culture environments, paving the way for future testing approaches for dipeptides in cell-free environments prior to use in large-scale bioreactors. Thus, this study provides a deeper understanding of the fate of dipeptides in CHO cell cultures through an integration of cell culture, 13C labeling, and kinetic modeling approaches providing insights in how to best use dipeptides in media formulations for robust and optimal mammalian cell culture performance.
包括单克隆抗体在内的生物制剂市场的快速增长刺激了对改进生物制造工艺的需求,包括哺乳动物宿主系统,如中国仓鼠卵巢 (CHO) 细胞。细胞培养基配方不断改进,以强化细胞培养过程并优化细胞培养性能。氨基酸是细胞培养基的主要成分,被 CHO 细胞大量消耗。由于溶解度低、稳定性差,包括酪氨酸、亮氨酸和苯丙氨酸在内的某些氨基酸会带来重大挑战,导致生物工艺性能不达标。二肽有可能取代培养基中的氨基酸。然而,人们对二肽在 CHO 细胞培养物中的裂解、吸收和利用动力学知之甚少。在这项研究中,用各自的二肽(包括但不限于 Ala-Leu 和 Gly-Tyr)取代氨基酸(包括亮氨酸和酪氨酸),可支持相似的细胞生长、抗体产生和乳酸分布。使用 13C 标记技术和废培养基研究表明,二肽在培养物中会发生细胞内和细胞外裂解。细胞外裂解随着培养时间的延长而增加,这表明宿主细胞蛋白可能会分泌裂解二肽,并随着时间的推移在细胞培养物中积累。我们建立了一个动力学模型,并首次将该模型与 13C 标记实验相结合,以估算二肽在 CHO 细胞培养物中的利用率。N端为丙氨酸的二肽的利用率高于C端为丙氨酸的二肽和N端为甘氨酸而非丙氨酸的二肽。在培养过程中同时补充一种以上的二肽会导致单个二肽的利用率降低,这表明二肽会竞争相同的裂解酶、转运体或两者。培养物中的二肽利用率和无细胞实验中的裂解率似乎遵循迈克尔-门顿动力学,在二肽浓度较高时达到最大值。研究发现,二肽在无细胞环境和细胞培养环境中的利用行为相似,这为今后在大规模生物反应器中使用二肽之前,在无细胞环境中测试二肽的方法铺平了道路。因此,这项研究通过整合细胞培养、13C 标记和动力学建模方法,加深了对二肽在 CHO 细胞培养物中命运的理解,为如何在培养基配方中最佳使用二肽以实现稳健、最佳的哺乳动物细胞培养性能提供了见解。
期刊介绍:
Metabolic Engineering (MBE) is a journal that focuses on publishing original research papers on the directed modulation of metabolic pathways for metabolite overproduction or the enhancement of cellular properties. It welcomes papers that describe the engineering of native pathways and the synthesis of heterologous pathways to convert microorganisms into microbial cell factories. The journal covers experimental, computational, and modeling approaches for understanding metabolic pathways and manipulating them through genetic, media, or environmental means. Effective exploration of metabolic pathways necessitates the use of molecular biology and biochemistry methods, as well as engineering techniques for modeling and data analysis. MBE serves as a platform for interdisciplinary research in fields such as biochemistry, molecular biology, applied microbiology, cellular physiology, cellular nutrition in health and disease, and biochemical engineering. The journal publishes various types of papers, including original research papers and review papers. It is indexed and abstracted in databases such as Scopus, Embase, EMBiology, Current Contents - Life Sciences and Clinical Medicine, Science Citation Index, PubMed/Medline, CAS and Biotechnology Citation Index.